DrugPatentWatch Database Preview
WYNZORA Drug Patent Profile
Email this page to a colleague
When do Wynzora patents expire, and when can generic versions of Wynzora launch?
Wynzora is a drug marketed by MC2 and is included in one NDA. There is one patent protecting this drug.
This drug has nineteen patent family members in fourteen countries.
The generic ingredient in WYNZORA is betamethasone dipropionate; calcipotriene. There are sixty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.
DrugPatentWatch® Generic Entry Outlook for Wynzora
Indicators of Generic Entry
Summary for WYNZORA
| International Patents: | 19 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in WYNZORA? | WYNZORA excipients list |
| DailyMed Link: | WYNZORA at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for WYNZORA
US Patents and Regulatory Information for WYNZORA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mc2 | WYNZORA | betamethasone dipropionate; calcipotriene | CREAM;TOPICAL | 213422-001 | Jul 20, 2020 | RX | Yes | Yes | ⤷ Free Forever Trial | ⤷ Free Forever Trial | Y | ⤷ Free Forever Trial | |||
| Mc2 | WYNZORA | betamethasone dipropionate; calcipotriene | CREAM;TOPICAL | 213422-001 | Jul 20, 2020 | RX | Yes | Yes | ⤷ Free Forever Trial | ⤷ Free Forever Trial | ⤷ Free Forever Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for WYNZORA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Taiwan | I434705 | ⤷ Free Forever Trial |
| Spain | 2368535 | ⤷ Free Forever Trial |
| Russian Federation | 2009138045 | ⤷ Free Forever Trial |
| Austria | 516797 | ⤷ Free Forever Trial |
| World Intellectual Property Organization (WIPO) | 2008110815 | ⤷ Free Forever Trial |
| Canada | 2680405 | ⤷ Free Forever Trial |
| European Patent Office | 1970049 | ⤷ Free Forever Trial |
| >Country | >Patent Number | >Estimated Expiration |
